Cost Effectiveness Analysis of Sorafenib Versus Best Supportive Care in Patients with Advanced Hepatocellular Carcinoma from Health Care System Perspective in Egypt

Value in Health ◽

10.1016/j.jval.2017.08.235 ◽

2017 ◽

Vol 20 (9) ◽

pp. A439

Author(s):

Elkony ◽

GH Elsisi

Keyword(s):

Hepatocellular Carcinoma ◽

Health Care ◽

Cost Effectiveness ◽

Supportive Care ◽

Health Care System ◽

Best Supportive Care ◽

Cost Effectiveness Analysis ◽

Advanced Hepatocellular Carcinoma ◽

System Perspective ◽

Effectiveness Analysis

Download Full-text

PCN68 COST-EFFECTIVENESS ANALYSIS OF SORAFENIB VERSUS BEST SUPPORTIVE CARE (BSC) IN ADVANCED HEPATOCELLULAR CARCINOMA (AHCC): THE PRIVATE HEALTH CARE SYSTEM PERSPECTIVE IN BRAZIL

Value in Health ◽

10.1016/s1098-3015(10)72157-4 ◽

2010 ◽

Vol 13 (3) ◽

pp. A36

Author(s):

N Muszbeck ◽

H Vioix ◽

U Munir ◽

A Schiola ◽

A Valderrama ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Health Care ◽

Cost Effectiveness ◽

Supportive Care ◽

Health Care System ◽

Best Supportive Care ◽

Advanced Hepatocellular Carcinoma ◽

Private Health Care ◽

System Perspective ◽

Effectiveness Analysis

Download Full-text

PIN17 COST-EFFECTIVENESS ANALYSIS OF THE NEW PCV-13 VACCINE WHEN COMPARED TO NO VACCINATION FROM A PUBLIC HEALTH-CARE SYSTEM PERSPECTIVE IN HONG KONG

Value in Health ◽

10.1016/s1098-3015(11)73297-1 ◽

2010 ◽

Vol 13 (7) ◽

pp. A549

Author(s):

KK Lee ◽

DP Chow

Keyword(s):

Public Health ◽

Health Care ◽

Hong Kong ◽

Cost Effectiveness ◽

Health Care System ◽

Cost Effectiveness Analysis ◽

Public Health Care ◽

Public Health Care System ◽

System Perspective ◽

Effectiveness Analysis

Download Full-text

PCN24 COST-EFFECTIVENESS ANALYSIS OF LAPATINIB ASSOCIATED TO CAPECITABINE VERSUS CAPECITABINE ALONE AND OF TRASTUZUMAB ASSOCIATED TO CAPECITABINE VERSUS CAPECITABINE ALONE IN THE TREATMENT OF METASTATIC BREAST CANCER UNDER THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM PERSPECTIVE

Value in Health ◽

10.1016/s1098-3015(10)75351-1 ◽

2009 ◽

Vol 12 (7) ◽

pp. A497

Author(s):

V Teich ◽

RBF Passos ◽

N Teich ◽

M Canella

Keyword(s):

Breast Cancer ◽

Health Care ◽

Metastatic Breast Cancer ◽

Cost Effectiveness ◽

Health Care System ◽

Metastatic Breast ◽

Cost Effectiveness Analysis ◽

Private Health Care ◽

System Perspective ◽

Effectiveness Analysis

Download Full-text

CC3 COST-EFFECTIVENESS ANALYSIS OF VORETIGENE NEPARVOVEC VERSUS BEST SUPPORTIVE CARE IN PATIENTS WITH RPE65-MEDIATED INHERITED RETINAL DYSTROPHY: A FRENCH HEALTHCARE SYSTEM PERSPECTIVE

Value in Health ◽

10.1016/j.jval.2019.09.047 ◽

2019 ◽

Vol 22 ◽

pp. S405 ◽

Author(s):

C. Cariou ◽

J. Baba ◽

A. Gherardi ◽

S. Roze ◽

D. Viriato

Keyword(s):

Cost Effectiveness ◽

Supportive Care ◽

Healthcare System ◽

Retinal Dystrophy ◽

Best Supportive Care ◽

Cost Effectiveness Analysis ◽

System Perspective ◽

Healthcare System Perspective ◽

Effectiveness Analysis ◽

Inherited Retinal Dystrophy

Download Full-text

PCN64 COST-EFFECTIVENESS ANALYSIS OF SORAFENIB VERSUS BEST SUPPORTIVE CARE (BSC) IN ADVANCED HEPATOCELLULAR CARCINOMA (AHCC): THE PUBLIC HEALTH CARE SYSTEM PERSPECTIVE IN BRAZIL

Value in Health ◽

10.1016/s1098-3015(10)72153-7 ◽

2010 ◽

Vol 13 (3) ◽

pp. A35

Author(s):

N Muszbeck ◽

U Munir ◽

H Vioix ◽

A Schiola ◽

A Valderrama ◽

...

Keyword(s):

Public Health ◽

Hepatocellular Carcinoma ◽

Health Care ◽

Best Supportive Care ◽

Public Health Care ◽

Advanced Hepatocellular Carcinoma ◽

Public Health Care System ◽

System Perspective ◽

Effectiveness Analysis

Download Full-text

Oxaliplatin plus fluorouracil/leucovorin or sorafneib as first-line treatments for advanced hepatocellular carcinoma: a cost-effectiveness analysis.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e18270 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e18270-e18270

Author(s):

Pengfei Zhang ◽

Feng Wen ◽

Qiu Li

Keyword(s):

Hepatocellular Carcinoma ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Advanced Hepatocellular Carcinoma ◽

Effectiveness Analysis

Download Full-text

Cost Effectiveness Analysis of Pirfenidone For The Treatment of Mild To Moderate Idiopathic Pulmonary Fibrosis (IPF) Compared To Best Supportive Care And Nintedanib From The Italian NHS Perspective

Value in Health ◽

10.1016/j.jval.2016.09.1211 ◽

2016 ◽

Vol 19 (7) ◽

pp. A556 ◽

Author(s):

R Ravasio ◽

M Ferrario ◽

M Pata ◽

P Thuresson

Keyword(s):

Cost Effectiveness ◽

Idiopathic Pulmonary Fibrosis ◽

Pulmonary Fibrosis ◽

Supportive Care ◽

Best Supportive Care ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

Cost-Effectiveness Analysis of Landiolol, an Ultrashort-Acting Beta-Blocker, for Prevention of Postoperative Atrial Fibrillation for the Germany Health Care System

Journal of Cardiothoracic and Vascular Anesthesia ◽

10.1053/j.jvca.2019.11.003 ◽

2020 ◽

Vol 34 (4) ◽

pp. 888-897

Author(s):

Evelyn Walter ◽

Matthias Heringlake

Keyword(s):

Atrial Fibrillation ◽

Health Care ◽

Cost Effectiveness ◽

Health Care System ◽

Beta Blocker ◽

Cost Effectiveness Analysis ◽

Postoperative Atrial Fibrillation ◽

Effectiveness Analysis ◽

Download Full-text

OnabotulinumtoxinA in the treatment of overactive bladder: a cost-effectiveness analysis versus best supportive care in England and Wales

The European Journal of Health Economics ◽

10.1007/s10198-015-0737-2 ◽

2015 ◽

Vol 17 (7) ◽

pp. 911-921 ◽

Author(s):

Nick Freemantle ◽

Kristin Khalaf ◽

Clara Loveman ◽

Sanja Stanisic ◽

Dmitry Gultyaev ◽

...

Keyword(s):

Cost Effectiveness ◽

Overactive Bladder ◽

Supportive Care ◽

Best Supportive Care ◽

Cost Effectiveness Analysis ◽

England And Wales ◽

Effectiveness Analysis

Download Full-text

Cost-Effectiveness Analysis of Oxaliplatin Plus Fluorouracil/Leucovorin (Folfox4) Compared to Sorafenib for Treatment of Advanced Hepatocellular Carcinoma Patients in China

Value in Health ◽

10.1016/j.jval.2016.08.277 ◽

2016 ◽

Vol 19 (7) ◽

pp. A889

Author(s):

SK Qin ◽

E Kruger ◽

SC Tan ◽

SQ Cheng ◽

XX Yao ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Advanced Hepatocellular Carcinoma ◽

Effectiveness Analysis

Download Full-text